This finding can be attributed to the role of c-Myc in epithelial to mesenchymal transition (EMT), based on the data reported by Cheng et al., (2011) that sarcomatoid variant represents the final pathway of BC dedifferentiation and EMT is responsible for this transformation. The gene discussed is MYC; the disease is breast cancer.